Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip
Recalled by Safecor Health, LLC
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Safecor Health, LLC has recalled Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on May 27, 2026 and was initiated on April 30, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, with approximately 149 capsules affected. The company behind the recall is Safecor Health, LLC, based in Columbus, OH. The FDA describes the product as: “Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01”
Why was Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip recalled?
According to the FDA, the stated reason for the recall is: “Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.”
What should you do?
If you think you may have bought Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, compare it against the product description and identifying codes (Lot #: 25530722) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Safecor Health, LLC or your local health authority.
About this recall
This recall was distributed in OH. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- May 27, 2026
- Recall started
- April 30, 2026
- Distributed in
- OH
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip recalled?+
According to the FDA: Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0538-2026. Information last synced from the FDA on July 6, 2026.